Found: 4
Select item for more details and to access through your institution.
PARP-1-targeted Auger emitters display high-LET cytotoxic properties in vitro but show limited therapeutic utility in solid tumor models of human neuroblastoma.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.233965
- By:
- Publication type:
- Article
PARP Theranostic Auger Emitters Are Cytotoxic in BRCA Mutant Ovarian Cancer and Viable Tumors from Ovarian Cancer Patients Enable Ex-Vivo Screening of Tumor Response.
- Published in:
- Molecules, 2020, v. 25, n. 24, p. 6029, doi. 10.3390/molecules25246029
- By:
- Publication type:
- Article
In vitro characterization of [<sup>125</sup>I] HY-3-24, a selective ligand for the dopamine D3 receptor.
- Published in:
- Frontiers in Neuroscience, 2024, p. 1, doi. 10.3389/fnins.2024.1380009
- By:
- Publication type:
- Article
Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma.
- Published in:
- Communications Biology, 2022, v. 5, n. 1, p. 1, doi. 10.1038/s42003-022-04209-8
- By:
- Publication type:
- Article